Effects of therapy with lansoprazole on intestinal permeability and inflammation in young cystic fibrosis patients

Journal of Pediatric Gastroenterology and Nutrition

Volumn 33, Issue 3, 2001, Pages 260-265

  Hendriks, Han J E ^a   Van Kreel, Bernard ^a   Forget, Philippe P ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cystic fibrosis; Gut acidity; Inflammation; Intestinal permeability; Lansoprazole; Nitric oxide products

Indexed keywords

LANSOPRAZOLE; PROTON PUMP INHIBITOR;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CYSTIC FIBROSIS; DRUG EFFECT; FEMALE; HUMAN; INTESTINE MUCOSA PERMEABILITY; LUNG DISEASE; MALE; PANCREAS INSUFFICIENCY; PANCREAS SECRETION; PRIORITY JOURNAL; TREATMENT OUTCOME; URINARY EXCRETION;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADOLESCENT; ANTI-INFECTIVE AGENTS; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; FEMALE; HUMANS; INFLAMMATION; INTESTINES; LACTULOSE; LONGITUDINAL STUDIES; MALE; MANNITOL; NITRIC OXIDE; OMEPRAZOLE; PERMEABILITY; RHAMNOSE;

EID: 0034784191     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005176-200109000-00006     Document Type: Article

References (33)

1. Lactulose-rhamnose intestinal permeability in children with cystic fibrosis
2. Intestinal permeability to [51Cr]EDTA in children with cystic fibrosis
3. The effect of intestinal permeability on pancreatic enzyme-induced enteropathy in the rat
4. Gastrointestinal pH, motility/transit and permeability in cystic fibrosis
5. Correlation of intestinal lactulose permeability with exocrine pancreatic dysfunction
6. Active passive sugar absorption in pancreatic insufficiency
7. Intestinal permeability in cystic fibrosis in relation to genotype
8. CFTR drives Na+nHCO-3 cotransport in pancreatic duct cells: A basis for defective HCO-3 secretion in CF
9. Omeprazole enhances the efficacy of pancreatin (pancrease) in CF
10. Effects of a proton-pump inhibitor in CF
11. Improvement of fecal fat excretion after addition of omeprazole to pancrease in CF is related to residual exocrine function of the pancreas
12. Duodenal fluid pH in CF
13. Pancrease gastroresistance: In vitro evaluation op pH-determined dissolution
14. Increased urinary nitric oxidation products in children with active coeliac disease
15. Presence of inducible nitric oxide synthethase, nitrotyrosine, CD68, and CD14 in the small intestine in celiac disease
16. Effects of nitric oxide and nitric oxide-derived species on prostaglandine endoperoxide synthase and prostaglandin biosynthesis
17. Rapid and simultaneous quantification of rhamnose, mannitol and lactulose in urine by HPLC for estimating IP in pediatric practice
18. Repeatability of the sugar-absorption test, using lactulose and mannitol for measuring intestinal permeability for sugars
19. Measurement of nitrite and nitrate in plasma, serum and urine by HPLC, the Griess assay, chemiluminescense and gas chromatography-mass spectrometry: Interference by biogenic amines and N(G)-nitro-L-arginine analogs
20. The acid steatocrit: A much improved method
21. Acid steatocrit during infancy
22. Clinical use of acid steatocrit
23. Changes in pulmonary hyperinflation and bronchial hyperresponsiveness in children with cystic fibrosis during treatment with lansoprazole
24. Intestinal permeability in exocrine pancreatic insufficiency due to cystic fibrosis or chronic pancreatitis
25. Intestinal permeability: Functional assessment and significance
26. Fetal abnormalities in CF suggest a deficiency in proteolysis of cholecystokinin
27. Intestinal inflammation in CF
28. Evidence of chronic inflammation in morphologically normal small intestine of CF patients
29. Twenty-four hour ambulatory gastric and duodenal pH profiles in cystic fibrosis: Effect of duodenal hyperacidity on pancreatic enzyme function and fat absorption
30. The sugar permeability test reflects disease activity in children adolescents with inflammatory bowel disease
31. Ultrastructural lesions in the small bowel of patients with CF
32. Significantly increased levels of nitric oxide products in urine of children with celiac disease
33. Early pulmonary inflammation in infants with CF